Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a study that will look at the effects and how useful investigational drug olaparib is as a neoadjuvant treatment (treatment given as to shrink a tumor before the main treatment) prior to surgery in patients with recurrent ovarian, primary peritoneal or fallopian tube cancer.
Critère d'inclusion
- Ovarian Cancer,Fallopian Tube Cancer,Neoadjuvant Treatment,Debulking Surgical Procedures